The Pleasanton Athletic Center offers premier fitness and training for Pleasanton and Atascosa County. The facility has new classes and new lower membership rates.

Pleasanton TX – July 31, 2017 /MarketersMedia/ —

Pleasanton Athletic Center and Karen Fuselier are pleased to announce that there are new lower membership rates and new classes at the premier fitness and training center in Pleasanton and Atascosa County. The Pleasanton gym facility offers Les Mills group classes by trained and certified instructors, state-of-the-art training equipment, small group personalized training with the original PAC FIIT, Zumba fitness, and Silver Sneakers for seniors citizens. The gym is a judgment-free zone and supports anyone who is trying to live a healthier lifestyle.

According to a spokesperson for the center, “Whether you are seeking to get in shape and shed a few pounds or just trying to maintain your healthy lifestyle and gain some muscle, PAC has got it all. Our instructors are Les Mills Certified and audition for each class to ensure that the quality of each program meets PAC’s distinct standards. Coaches are NASM Certified, and they frequently meet to create specific workout regimens unique to Pleasanton Athletic Center.”

The front desk associates and PlayCare staff are carefully selected to represent PAC’s values and customer service. They strive to be the best fitness and training facility in South Texas and to meet the needs of the growing and diverse community. From highly-trained and competitive athletes, blue-collar workers and business people on a tight schedule, busy mothers with daily demands, students, and senior citizens to anyone who desires to be healthy and fit, PAC is the only gym in Atascosa County that caters to the needs of everybody.

The programs which mark the uniqueness of the athletic center include Les Mills Group Classes and Zumba sessions. The gym equipment is available for the use of patrons, and the instructors lead group training sessions for health and fitness. For patrons of the center, picking the preferred classes is easy and convenient.

Contact Info:
Name: Karen Fuselier
Organization: Pleasanton Athletic Center
Address: 1202 W Oaklawn Rd., Pleasanton TX 78064
Phone: (830) 569-3648

Source URL: http://marketersmedia.com/pleasanton-gym-announces-new-lower-membership-rates-and-new-classes/223565

For more information, please visit http://www.pleasantonathleticcenter.com/

Source: MarketersMedia

Release ID: 223565

Order a Report “Global Radiation Dose Management Market Size, Status And Forecast 2022” by Calling Research Trades at +1 6269994607

July 31, 2017 /MarketersMedia/ —

This report studies the global Radiation Dose Management market, analyses and researches the Radiation Dose Management development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Bayer AG (Germany)
GE Healthcare (U.S.)
PACSHealth LLC (U.S.)
Philips Healthcare (Netherlands)
Fujifilm Holdings Corporation (Japan)
Novarad Corporation (U.S.)
Siemens Healthineers (Germany)
AGFA Healthcare (Belgium)
Sectra AB (Sweden)
QAELUM N.V. (Belgium)
Bracco Imaging S.p.A. (Italy)
Medsquare (France)

Get Sample Copy of this report @ https://www.researchtrades.com/request-sample/1138205

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Radiation Dose Management can be split into
Standalone
Integrated Solutions
Consulting Services

Market segment by Application, Radiation Dose Management can be split into
Hospitals
Ambulatory Care Settings
Research Institutions and Academic Medical Centers

Buy a single user copy of this report (USD 3300) @ https://www.researchtrades.com/checkout/1138205

Table of Contents

Global Radiation Dose Management Market Size, Status and Forecast 2022
1 Industry Overview of Radiation Dose Management
1.1 Radiation Dose Management Market Overview
1.1.1 Radiation Dose Management Product Scope
1.1.2 Market Status and Outlook
1.2 Global Radiation Dose Management Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Radiation Dose Management Market by Type
1.3.1 Standalone
1.3.2 Integrated Solutions
1.3.3 Consulting Services
1.4 Radiation Dose Management Market by End Users/Application
1.4.1 Hospitals
1.4.2 Ambulatory Care Settings
1.4.3 Research Institutions and Academic Medical Centers

2 Global Radiation Dose Management Competition Analysis by Players
2.1 Radiation Dose Management Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Bayer AG (Germany)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 GE Healthcare (U.S.)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 PACSHealth LLC (U.S.)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Philips Healthcare (Netherlands)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Fujifilm Holdings Corporation (Japan)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Novarad Corporation (U.S.)
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Siemens Healthineers (Germany)
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AGFA Healthcare (Belgium)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Sectra AB (Sweden)
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 QAELUM N.V. (Belgium)
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Radiation Dose Management Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Bracco Imaging S.p.A. (Italy)
3.12 Medsquare (France)

Continued…

Customize this report, according to your requirements @ https://www.researchtrades.com/report-customization

Contact Info:
Name: Pranav Shelar
Organization: Research Trades
Phone: +16269994607

Source URL: http://marketersmedia.com/radiation-dose-management-market-professional-survey-trends-by-product-and-application-2017/223584

For more information, please visit https://www.researchtrades.com/report/global-radiation-dose-management-market-size-status-and-forecast-2022/1138205

Source: MarketersMedia

Release ID: 223584

The new report “Global Hemostats Market” has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% during 2017 to 2024.

Pune, India – July 31, 2017 /MarketersMedia/ —

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.

Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market-trends-forecast24&utm_source=Marketers%20Media&utm_campaign=Varsha%20Chaudhari

Global Hemostats Market – Segmentation:

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats Market is also segmented based on indications type into wound closure and surgery

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.

Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market-trends-forecast24&utm_source=Marketers%20Media&utm_campaign=Varsha%20Chaudhari

Global Hemostats Market – Geographical Segmentation

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.

Global Hemostats Market – Competitive Landscape:

Some of the major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, Medtrade Products Ltd., Integra Lifesciences Corporation, Medline Industries, Inc., Hemotec Medical GmbH, Stryker, Hemostasis, LLC., CSL Behring, Mallinckrodt plc. and Equimedical, B.V. among other companies.

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/global-hemostats-market-trends-forecast-2024/?utm_source=Marketers%20Media&utm_campaign=Varsha%20Chaudhari
Table of Content:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
10.19. STRYKER
10.19.1. OVERVIEW
10.19.2. SWOT ANALYSIS
10.19.3. PRODUCT PORTFOLIO
10.19.4. REVENUE ANALYSIS
10.19.5. ANALYSTS VIEW
10.20. HEMOSTASIS, LLC.
10.20.1. OVERVIEW
10.20.2. SWOT ANALYSIS
10.20.3. PRODUCT PORTFOLIO
10.20.4. REVENUE ANALYSIS
10.20.5. ANALYSTS VIEW
10.21. CSL BEHRING
10.21.1. OVERVIEW
10.21.2. SWOT ANALYSIS
10.21.3. PRODUCT PORTFOLIO
10.21.4. REVENUE ANALYSIS
10.21.5. ANALYSTS VIEW
10.22. MALLINCKRODT PLC.
10.22.1. OVERVIEW
10.22.2. SWOT ANALYSIS
10.22.3. PRODUCT PORTFOLIO
10.22.4. REVENUE ANALYSIS
10.22.5. ANALYSTS VIEW
10.23. EQUIMEDICAL, B.V.
10.23.1. OVERVIEW
10.23.2. SWOT ANALYSIS
10.23.3. PRODUCT PORTFOLIO
10.23.4. REVENUE ANALYSIS
10.23.5. ANALYSTS VIEW

Related Report

Global Medical Instruments Disinfections Market – Trends and Forecast to 2024

Global Medical Instruments Disinfection Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors, Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/medical-devices/healthcare-manufacturing/global-medical-instruments-disinfections-market-trends-forecast-2024/?utm_source=Marketers%20Media&utm_campaign=Varsha%20Chaudhari

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Info:
Name: Ankit Singh
Email: Sales@databridgemarketresearch.com
Organization: Data Bridge Market Research
Address: Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-888-387-2818

Source URL: http://marketersmedia.com/hemostats-market-global-industry-share-trends-size-and-forecast-2017-to-2024/223573

For more information, please visit http://databridgemarketresearch.com/reports/global-hemostats-market-trends-forecast-2024/?utm_source=Marketers%20Media&utm_campaign=Varsha%20Chaudhari

Source: MarketersMedia

Release ID: 223573

Pune, India, 31st July 2017: WiseGuyReports announced addition of new report, titled “EpiCast Report: Acute Myeloid Leukemia – Epidemiology Forecast to 2026”.

Pune, India – July 31, 2017 /MarketersMedia/ —

Summary
Acute myeloid leukemia (AML) is a rare cancer that accounts for a disproportionally high number of cancer-related deaths. The disease is more common in the elderly, and is relatively more common in men than in women. AML progresses quickly, has low survival rates, and has high rates of relapse, even with treatment. The cause of AML is unknown, but an increased risk of the disease is associated with factors such as age, male sex, a history of smoking, and exposure to high doses of radiation and cytotoxic chemicals. Due to the rarity of the disease, the relationships between most risk factors and the disease have not been strongly established through epidemiological studies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1646375-epicast-report-acute-myeloid-leukemia-epidemiology-forecast-to-2026
In 2016, the 7MM had 43,592 diagnosed incident cases of AML. This is expected to increase to 52,526 diagnosed incident cases of AML by 2026, at an Annual Growth Rate (AGR) of 2.05%. The increase is driven by the aging population in the 7MM. In 2016, the 7MM had 57,581 five-year diagnosed prevalent cases of AML. This is expected to increase to 66,743 by 2026, at an AGR of 1.54%. The US had the highest number of diagnosed incident and five-year prevalent cases of AML. The development of more effective therapies, particularly for elderly patients, would improve survival and increase disease prevalence.

The use of a consistent methodology across the 7MM to forecast the diagnosed incident cases and the diagnosed five-year prevalent cases of AML allows for a meaningful comparison of the forecast incident cases and the forecast five-year prevalent cases of AML in these markets. Additionally, GlobalData epidemiologists provide a detailed segmentation of the diagnosed incident and five-year diagnosed prevalent cases of AML by subtypes and risk group classification, which are both important factors for predicting the prognosis in patients as well as specific treatment modalities for AML. Finally, this report reflects numerous updates to the AML literature, including more up-to-date, country-specific AML incidence rates, the impact of coding differences on incidence, and more up-to-date relative survival rates.

Scope
– The Acute Myeloid Leukemia (AML) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of AML in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the following segmentations in ages 18 years and older across the 7MM: diagnosed incident cases of AML, segmented by ages 18-59 years and ages 60 years and older; five-year diagnosed prevalent cases of AML, segmented by ages 18-59 years and ages 60 years and older; diagnosed incident cases of (acute promyelocytic leukemia) APL and secondary AML, segmented by ages 18-59 years and ages 60 years and older; diagnosed incident cases of AML with mutations (FLT3-ITD [internal tandem duplications], FLT3-TKD [tyrosine kinase domain], IDH [isocitrate dehydrogenase] 1 and IDH2), core binding factor (CBF) AML with KIT mutation, and biomarker CD33+; and diagnosed incident cases of AML classified into favorable-, intermediate-, and adverse-risk groups.
– The AML epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy
The AML EpiCast report will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global AML market.
– Quantify patient populations in the global AML market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AML therapeutics in each of the markets covered.
– Identify the percentage of AML diagnosed incident and five-year diagnosed prevalent cases by various clinical segmentations.

Table of Content: Key Points
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Acute Myeloid Leukemia: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global and Historical Trends 10
3.4 Forecast Methodology 13
3.5 Epidemiological Forecast for Acute Myeloid Leukemia (2016-2026) 29
3.6 Discussion 37
4 Appendix
…Continued

ACCESS REPORT @https://www.wiseguyreports.com/reports/1646375-epicast-report-acute-myeloid-leukemia-epidemiology-forecast-to-2026

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune – 411028 Maharashtra, India
Phone: +44 208 133 9349

Source URL: http://marketersmedia.com/acute-myeloid-leukemia-therapeutics-development-and-professional-review-analysis-2026/223485

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 223485

Chocolate Syrup Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

July 31, 2017 /MarketersMedia/ —

Chocolate syrup is a chocolate-flavored condiment often used as a topping or dessert sauce for ice creams, mixed with milk to make chocolate milk, and blended with milk and ice cream to make chocolate milkshake. Chocolate syrups are sold in a variety of consistencies like a thin liquid or a thick sauce. Chocolate syrup is made using cocoa powder, corn syrup, sugar base, natural or artificial flavorings, and water. It is used as a flavor enhancer in tea and coffee.

Publisher’s analysts forecast the global chocolate syrup market to grow at a CAGR of 4.87% during the period 2017-2021.

Complete Report Available at: http://www.reportsweb.com/global-chocolate-syrup-market-2017-2021 .

Covered in this report
The report covers the present scenario and the growth prospects of the global chocolate syrup market for 2017-2021. To calculate the market size, the report considers the sales and value of the market.

The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA

Publisher’s report, Global Chocolate Syrup Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
-Nestlé
-R. Torre & Co. (Torani)
-Hershey
-The J.M. Smucker Company

Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001894403/sample .

Other prominent vendors
-AH!LASKA
-American Garden
-Amoretti
-Bosco Products
-DaVinci Gourmet
-H. Fox & Co.
-Monin
-Sonoma Syrup
-Tropicana Slim
-Walden Farms
-Wilderness Family Naturals

Market driver
-Growing number of cafés
-For a full, detailed list, view our report

Market challenge
-Growing health concerns about diabetes and obesity
-For a full, detailed list, view our report

Market trend
-Rise in demand for Fairtrade-certified organic cocoa
-For a full, detailed list, view our report

Inquire about Report at: http://www.reportsweb.com/inquiry&RW0001894403/buying .

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by distribution channel
PART 07: Market segmentation by product type
PART 08: Market segmentation by end-user
PART 09: Geographical segmentation
PART 10: Key leading countries
PART 11: Decision framework
PART 12: Drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix

Purchase this Report at: http://www.reportsweb.com/buy&RW0001894403/buy/3500 .

Contact Info:
Name: Sameer Joshi
Email: sales@reportsweb.com
Organization: ReportsWeb
Address: Pune, India.
Phone: +1-646-491-9876

Source URL: http://marketersmedia.com/chocolate-syrup-market-2017-by-distribution-channel-product-type-geography-analysis-and-forecast-to-2021/223494

For more information, please visit http://www.reportsweb.com/global-chocolate-syrup-market-2017-2021

Source: MarketersMedia

Release ID: 223494

Pune, India, 31st July 2017: WiseGuyReports announced addition of new report, titled “Contact Lenses – Medical Devices Pipeline Assessment, 2017”.

Pune, India – July 31, 2017 /MarketersMedia/ —

Summary
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Contact Lenses pipeline products.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1646384-contact-lenses-medical-devices-pipeline-assessment-2017

Scope
– Extensive coverage of the Contact Lenses under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Contact Lenses under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Content: Key Points
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Contact Lenses Overview 12
3 Products under Development 13
3.1 Contact Lenses – Pipeline Products by Stage of Development 13
3.2 Contact Lenses – Pipeline Products by Segment 14
3.3 Contact Lenses – Pipeline Products by Territory 15
3.4 Contact Lenses – Pipeline Products by Regulatory Path 16
3.5 Contact Lenses – Pipeline Products by Estimated Approval Date 17
3.6 Contact Lenses – Ongoing Clinical Trials 18
4 Contact Lenses – Pipeline Products under Development by Companies 19
4.1 Contact Lenses Companies – Pipeline Products by Stage of Development 19
4.2 Contact Lenses – Pipeline Products by Stage of Development 21
5 Contact Lenses Companies and Product Overview 23
5.1 Aeon Astron Corporation Company Overview 23
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1646384-contact-lenses-medical-devices-pipeline-assessment-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune – 411028 Maharashtra, India
Phone: +44 208 133 9349

Source URL: http://marketersmedia.com/contact-lenses-therapeutics-development-and-professional-review-analysis-2017/223498

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 223498

Wiseguyreports.Com Added New Market Research Report On -“Global Automotive OLED Market 2017 Top Manufacturers, Production , Growth and Future Demand Forecast to 2022”.

Pune, India – July 31, 2017 /MarketersMedia/ —

Global Automotive OLED Market

Description

This report studies Automotive OLED in Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Osram
Philips
Astron FIAMM
LG Chem
GE
Konica Minolta
Winstar
Visteon
Nippon Seiki

Get sample Report @  https://www.wiseguyreports.com/sample-request/1652996-global-automotive-oled-market-professional-survey-report-2017

 By types, the market can be split into
Exterior Lighting
Interior Lighting

By Application, the market can be split into
Commercial Cars
Passenger Cars

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Complete Report Details @ https://www.wiseguyreports.com/reports/1652996-global-automotive-oled-market-professional-survey-report-2017

 Table of Contents -Major Key Points

Global Automotive OLED Market Professional Survey Report 2017
1 Industry Overview of Automotive OLED
1.1 Definition and Specifications of Automotive OLED
1.1.1 Definition of Automotive OLED
1.1.2 Specifications of Automotive OLED
1.2 Classification of Automotive OLED
1.2.1 Exterior Lighting
1.2.2 Interior Lighting
1.3 Applications of Automotive OLED
1.3.1 Commercial Cars
1.3.2 Passenger Cars
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

8 Major Manufacturers Analysis of Automotive OLED
8.1 Osram
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Osram 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Osram 2016 Automotive OLED Business Region Distribution Analysis
8.2 Philips
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Philips 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Philips 2016 Automotive OLED Business Region Distribution Analysis
8.3 Astron FIAMM
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Astron FIAMM 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Astron FIAMM 2016 Automotive OLED Business Region Distribution Analysis
8.4 LG Chem
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 LG Chem 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 LG Chem 2016 Automotive OLED Business Region Distribution Analysis
8.5 GE
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 GE 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GE 2016 Automotive OLED Business Region Distribution Analysis
8.6 Konica Minolta
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Konica Minolta 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Konica Minolta 2016 Automotive OLED Business Region Distribution Analysis
8.7 Winstar
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Winstar 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Winstar 2016 Automotive OLED Business Region Distribution Analysis
8.8 Visteon
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Visteon 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Visteon 2016 Automotive OLED Business Region Distribution Analysis
8.9 Nippon Seiki
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Nippon Seiki 2016 Automotive OLED Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Nippon Seiki 2016 Automotive OLED Business Region Distribution Analysis
………..CONTINUED

 
Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1652996

Contact Info:
Name: Norah Trent
Email: Sales@wiseguyreports.com
Organization: WiseGuy Research Consultants Pvt. Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/automotive-oled-global-industry-market-2017-analysis-and-forecast-to-2022/223496

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 223496